A Comparison of Three Surgical Approaches to Zygomaticomaxillary Fractures

Sponsor
University of Alexandria (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05695872
Collaborator
(none)
24
1
3
5.2
4.6

Study Details

Study Description

Brief Summary

The study is a randomized controlled clinical trial, following the Consolidated Standards of Reporting Trials (CONSORT) guidelines. The study is intended to compare between the subtarsal approach, conventional transconjuctival approach and the Y- modification of the transconjuctival approach in the management of zygomatico-maxillay complex fracture.

Condition or Disease Intervention/Treatment Phase
  • Procedure: subtarsal approach
  • Procedure: conventional transconjunctival approach
  • Procedure: transconjunctival approach with Y- modification
N/A

Detailed Description

The study is a randomized controlled clinical trial. Twenty-four patients with age range of 20-50 years requiring open reduction and fixation of a fractured zygomatic complex were randomly divided into three equal groups according to the approach used:

Group A: subtarsal approach group. Group B: conventional transconjuctival approach group. Group C: Y- modification of the transconjuctival approach group.

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Best Approach to Zygomaticomaxillary Fractures: A Comparison of Three Surgical Approaches
Actual Study Start Date :
Aug 26, 2022
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: subtarsal approach

Procedure: subtarsal approach
surgical approach

Active Comparator: conventional transconjunctival approach

Procedure: conventional transconjunctival approach
surgical approach

Active Comparator: transconjunctival approach with Y- modification

Procedure: transconjunctival approach with Y- modification
surgical approach

Outcome Measures

Primary Outcome Measures

  1. accessibility to the fracture site [intraoperative]

    Adequate exposure provided by the incision and accessiblity to proper fracture reduction and fixation was assigned as Yes or No

  2. esthetic appearance and scarring [6 weeks postoperative]

    Postoperative scarring was recorded as noticeable or unnoticeable

  3. radiographic verification of adequacy of fracture reduction [immediate postoperative]

    computed tomography was requested for adequacy of fracture reduction assessment and this outcome was assigned as Yes or No

Secondary Outcome Measures

  1. The duration for exposure of the fracture site [intraoperative]

    The duration from performing the incision till the field exposure calculated in minutes

  2. postoperative pain [at 24 hours and 1 week]

    Pain was evaluated at 24 hours and at 1 week according to a 10-point Visual Analogue Scale (VAS), (0-1=none,2-4=mild,5-7=moderate,8-10=severe).

  3. sensory nerve function [3 months postoperative]

    Subjective assessment of the infraorbital nerve sensation by patient questioning about any alteration in sensation at 3 months postoperatively. Objective assessment by dental probe pressure to assess sensory changes along the distribution of the infraorbital nerve with contralateral side comparison

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with ZMC fractures requiring open reduction and internal fixation.

  • Adult patients aged between 20 and 50 years with no gender predilection.

Exclusion Criteria:
  • An existing laceration in the inferior and lateral periorbital site.

  • Infection at the fracture line.

  • Comminuted fracture with bone loss.

  • Acute and chronic conjunctival diseases.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry, Alexandria University Alexandria Egypt 21526

Sponsors and Collaborators

  • University of Alexandria

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lydia Nabil, Associate Professor of Oral and Maxillofacial Surgery, University of Alexandria
ClinicalTrials.gov Identifier:
NCT05695872
Other Study ID Numbers:
  • UAlexandriaMaxFacSurg
First Posted:
Jan 25, 2023
Last Update Posted:
Jan 27, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2023